RRX Stock Analysis: Regal Beloit | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 14.542m USD | 12M Return: 40.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 247M
EPS Trend: -83.2%
Qual. Beats: 0
Rev. Trend: -10.5%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Regal Rexnord Corporation (NYSE: RRX), formerly known as Regal Beloit Corporation, is a global manufacturer of power transmission and motion control products headquartered in Milwaukee, Wisconsin. Founded in 1955 and publicly traded since 1983, the company operates through three business segments: Automation & Motion Control, Industrial Powertrain Solutions, and Power Efficiency Solutions.
The company supplies a diverse range of industrial components, including bearings, gearboxes, motors, drives, couplings, and motion-control subsystems, serving end markets such as factory automation, aerospace, food and beverage, medical, data center, metals and mining, energy, and commercial HVAC. Its products span fractional motors up to approximately 5 horsepower AC and DC units.
Regal Rexnord is classified within the GICS Industrials sector under the Electrical Components & Equipment sub-industry, reflecting its focus on engineered industrial products. The company adopted the Regal Rexnord name following its 2021 acquisition of Rexnords Power Transmission business, which expanded its industrial powertrain offerings and global footprint.
- Data center demand boosts Power Efficiency Solutions revenue
- Industrial production slowdown pressures Powertrain Solutions orders
- Manufacturing reshoring lifts North American automation orders
| Net Income: 286.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.13 > 1.0 |
| NWC/Revenue: 24.77% < 20% (prev 26.00%; Δ -1.23% < -1%) |
| CFO/TA 0.07 > 3% & CFO 903.4m > Net Income 286.6m |
| Net Debt (4.62b) to EBITDA (1.19b): 3.87 < 3 |
| Current Ratio: 2.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (66.8m) vs 12m ago 0.45% < -2% |
| Gross Margin: 37.47% > 18% (prev 36.83%; Δ 0.64% > 0.5%) |
| Asset Turnover: 43.11% > 50% (prev 42.08%; Δ 1.04% > 0%) |
| Interest Coverage Ratio: 2.05 > 6 (EBIT TTM 694.4m / Interest Expense TTM 338.3m) |
| A: 0.11 (Total Current Assets 2.75b - Total Current Liabilities 1.26b) / Total Assets 13.8b |
| B: 0.16 (Retained Earnings 2.27b / Total Assets 13.8b) |
| C: 0.05 (EBIT TTM 694.4m / Avg Total Assets 13.9b) |
| D: 0.98 (Book Value of Equity 6.81b / Total Liabilities 6.97b) |
| Altman-Z'' = 2.61 = A |
| DSRI: 0.67 (Receivables 577.3m/852.1m, Revenue 6.00b/5.90b) |
| GMI: 0.98 (GM 36.83% / 37.47%) |
| AQI: 1.00 (AQ_t 0.73 / AQ_t-1 0.73) |
| SGI: 1.02 (Revenue 6.00b / 5.90b) |
| TATA: -0.04 (NI 286.6m - CFO 903.4m) / TA 13.8b) |
| Beneish M = -3.31 (Cap -4..+1) = AA |
As of July 09, 2026, the stock is trading at USD 208.44 with a total of 828,919 shares traded. Over the past week, the price has changed by -12.49%, over one month by -0.72%, over three months by +2.26% and over the past year by +40.59%.
Current recommended Stop Loss: 186.80 (which is 10.4% or 1.7 ATR below the current price).
Regal Beloit has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy RRX.
- StrongBuy: 8
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 253.2 | 21.5% |
P/E Trailing = 50.8023
P/E Forward = 20.3666
P/S = 2.4255
P/B = 2.1368
P/EG = 2.0359
Revenue TTM = 6.00b USD
EBIT TTM = 694.4m USD
EBITDA TTM = 1.19b USD
Long Term Debt = 4.68b USD (from longTermDebt, last quarter)
Short Term Debt = 63.9m USD (from shortTermDebt, last quarter)
Debt = 5.02b USD (from shortLongTermDebtTotal, last quarter) + Leases 155.5m
Net Debt = 4.62b USD (calculated: Debt 5.02b - CCE 401.0m)
Enterprise Value = 19.2b USD (14.5b + Debt 5.02b - CCE 401.0m)
Interest Coverage Ratio = 2.05 (Ebit TTM 694.4m / Interest Expense TTM 338.3m)
EV/FCF = 23.80x (Enterprise Value 19.2b / FCF TTM 805.1m)
FCF Yield = 4.20% (FCF TTM 805.1m / Enterprise Value 19.2b)
FCF Margin = 13.43% (FCF TTM 805.1m / Revenue TTM 6.00b)
Net Margin = 4.78% (Net Income TTM 286.6m / Revenue TTM 6.00b)
Gross Margin = 37.47% ((Revenue TTM 6.00b - Cost of Revenue TTM 3.75b) / Revenue TTM)
Gross Margin QoQ = 37.18% (prev 37.50%)
Tobins Q-Ratio = 1.39 (Enterprise Value 19.2b / Total Assets 13.8b)
Interest Expense / Debt = 6.74% (Interest Expense 338.3m / Debt 5.02b)
Taxrate = 19.21% (68.4m / 356.1m)
NOPAT = 561.0m (EBIT 694.4m * (1 - 19.21%))
Current Ratio = 2.17 (Total Current Assets 2.75b / Total Current Liabilities 1.26b)
Debt / Equity = 0.74 (Debt 5.02b / totalStockholderEquity, last quarter 6.81b)
Debt / EBITDA = 3.87 (Net Debt 4.62b / EBITDA 1.19b)
Debt / FCF = 5.73 (Net Debt 4.62b / FCF TTM 805.1m)
Total Stockholder Equity = 6.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.06% (Net Income 286.6m / Total Assets 13.8b)
RoE = 4.23% (Net Income TTM 286.6m / Total Stockholder Equity 6.78b)
RoCE = 6.06% (EBIT 694.4m / Capital Employed (Equity 6.78b + L.T.Debt 4.68b))
RoIC = 4.57% (NOPAT 561.0m / Invested Capital 12.3b)
WACC = 10.77% (E(14.5b)/V(19.6b) * Re(12.61%) + D(5.02b)/V(19.6b) * Rd(6.74%) * (1-Tc(0.19)))
Discount Rate = 12.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 44.72 | Cagr: 0.67%
[DCF] Terminal Value 70.55% ; FCFF base≈691.4m ; Y1≈792.5m ; Y5≈1.17b
[DCF] Fair Price = 115.2 (EV 12.3b - Net Debt 4.62b = Equity 7.67b / Shares 66.6m; r=10.77% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -83.15 | EPS CAGR: -11.53% | SUE: 0.26 | # QB: 0
Revenue Correlation: -10.45 | Revenue CAGR: -0.51% | SUE: 1.67 | # QB: 1
EPS current Quarter (2026-06-30): EPS=2.60 | Chg30d=+0.40% | Revisions=-77% | Analysts=10
EPS next Quarter (2026-09-30): EPS=2.92 | Chg30d=+0.04% | Revisions=+31% | Analysts=10
EPS current Year (2026-12-31): EPS=10.65 | Chg30d=+0.26% | Revisions=-18% | GrowthEPS=+10.3% | GrowthRev=+5.0%
EPS next Year (2027-12-31): EPS=13.54 | Chg30d=+0.15% | Revisions=+30% | GrowthEPS=+27.2% | GrowthRev=+13.5%
[Analyst] Revisions Ratio: -13% (up=15, down=20)